Medical Management of Diabetes and Heart Disease - part 3 ppt

... 1996; 35 1:181–189. 32 . Kahn CR. Diabetes. Causes of insulin resistance. Nature 1995; 37 3 :38 4 38 5. 33 . Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidyl- inositol 3- kinase ... and risk of complications in patients with type 2 diabetes (UKPDS 33 ). Lancet 1998; 35 2: 837 – 8 53. 70. UK Prospective Diabetes Study Group. Efficacy of atenolol a...

Ngày tải lên: 14/08/2014, 07:20

... 10016 tel: 21 2-6 9 6-9 000; fax: 21 2-6 8 5-4 540 Eastern Hemisphere Distribution Marcel Dekker AG Hutgasse 4, Postfach 812, CH-4001 Basel, Switzerland tel: 4 1-6 1-2 6 1-8 482; fax: 4 1-6 1-2 6 1-8 896 World Wide ... Figures 3 and 4 which plot cumulative mortality from coronary heart disease during 24 years of follow-up of a cohort of patients whose diabet...

Ngày tải lên: 14/08/2014, 07:20

... synthesis (37 ), and Glut-4 transloca- tion (34 ,40– 43) . Specifically, activation of PI -3 kinase has been reported to be necessary for insulin-stimulated glucose uptake in rat adipocytes (34 ,44), 3T 3- L1 ... certain lipid phenotype Types of Diabetes 33 increase the risk for coronary heart disease similarly in both low- and high-risk popu- lations? Diabetologia 1995; 3...

Ngày tải lên: 14/08/2014, 07:20

... 6: 33 7 34 7. 14. Trigatti B, Rigotti A, Krieger M. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism. Curr Opin Lipidol 2000; 11:1 23 131 . 15. Howard BV. Diabetes and ... evolution and persistence of thrombosis and the rapidity and extent of lysis of thrombi associated with vascular damage and its repair, overexpression of PAI-1 is like...

Ngày tải lên: 14/08/2014, 07:20

... (IRS-1 and IRS-2), and activation of the phosphoinositol 3 kinase (PI -3 -K) pathway. On the other hand, cell growth and differentiation are regu- lated primarily by the SHC, GRB-2, and the MAP-kinase ... sympathoadrenal system. N Engl J Med 1996; 33 4 :37 4 38 1. 9. Chen YD-I, Reaven GM. Insulin resistance and atherosclerosis. Diabetes Rev 1997; 5 :33 1 34 2. Syndrome X 119...

Ngày tải lên: 14/08/2014, 07:20

... 2000; 32 0:479–482. 60. Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syn- drome. Prevalence and significance. Am J Med 1982; 73: 317 32 1. Diagnosis of Heart Disease ... conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33 ). Lancet 1998; 35 2: 837 –8 53. 8. UK Prospective Diabetes Study Group. Effect...

Ngày tải lên: 14/08/2014, 07:20

... Med 1996; 28 :36 3 37 0. 32 . Haffner SM. The prediabetic problem: development of non-insulin-dependent diabe- tes mellitus and related abnormalities. J Diabetes Complic 1997; 11:69–76. 33 . Celentano ... lev- els of high-density-lipoprotein (HDL) cholesterol, and increased low-density-li- poprotein (LDL) cholesterol, hypertension, and central obesity with an increased waist-to-...

Ngày tải lên: 14/08/2014, 07:20

... PTCA- and CABG-treated patients even in subgroups of diabetes and three-vessel disease (31 ). In addition to the randomized trials com- paring PCI and CABG, three large, single-center registries and ... time of restenosis, that is 3 to 4 months post-intervention. For long-term follow-up of 268 Peragallo-Dittko Table 3 Recommendations Regarding Diabetes and Smoking As...

Ngày tải lên: 14/08/2014, 07:20

... University of Vermont College of Medicine and Physician-in-Chief, Fletcher Allen Health Care, Burlington, Ver- mont. The editor of Medical Management of Heart Disease (Marcel Dekker, Inc.) and the ... 191–1 93 trandolapril, 194 Myocardial ischemia, 171 Myocardial revascularization, 2 23 224, 232 – 237 adjunctive therapy, 247–251 balloon angioplasty, 233 – 239 vs. CABG,...

Ngày tải lên: 14/08/2014, 07:20